✦ LIBER ✦

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies

✍ Scribed by Alessandro Zuddas; Roberta Zanni; Tatiana Usala

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of second-generation

✍ David Fraguas; Christoph U. Correll; Jessica Merchán-Naranjo; Marta Rapado-Castr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Metabolic and endocrine adverse effects

✍ M. De Hert; M. Dobbelaere; E.M. Sheridan; D. Cohen; C.U. Correll 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 572 KB

A Randomized Controlled Trial of the Cos

✍ Linda M. Davies; Thomas R. E. Barnes; Peter B. Jones; Shôn Lewis; Fiona Gaughran 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

P.7.c.002 Risk of diabetes in children a

✍ R.E. Nielsen; D. Lammers; C. Bisgaard; D. Helenius 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Risperidone for the treatment of acute m

✍ Magali Haas; Melissa P DelBello; Gahan Pandina; Stuart Kushner; Ilse Van Hove; I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

CE2 Comparative Effectiveness of Monothe

✍ S. Mehta; A. Patel; R.R. Aparasu; M.O. Perez; H. Chen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB